Akiko Yamada

Dr. Akiko Yamada


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AYAkiko Yamada
Akiko Yamada
KWKiyotaka Wake
Kiyotaka Wake
SISaya Imaoka
Saya Imaoka
MMMitsuru Motoyoshi
Mitsuru Motoyoshi
TYTakenori Yamamoto
Takenori Yamamoto
MAMasatake Asano
Masatake Asano
Interleukin-1α (IL-1α), a cytokine released by necrotic cells, causes sterile inflammation. On the other hand, IL-1α is present in the nucleus and also regulates the expression of many proteins. A protein substrate containing a classical nuclear localization signal (cNLS) typically forms a substrate/importin α/β complex, which is subsequently transported to the nucleus. To the best of our knowledge, no study has directly investigated whether IL-1α—which includes cNLS—is imported into the nucleus in an importin α/β-dependent manner. In this study, we noted that all detected importin α subtypes interacted with IL-1α. In HeLa cells, importin α1-mediated nuclear translocation of IL-1α occurred at steady state and was independent of importin β1. Importin α1 not only was engaged in IL-1α nuclear transport but also concurrently functioned as a molecule that regulated IL-1α protein level in the cell. Furthermore, we discussed the underlying mechanism of IL-1α nuclear translocation by importin α1 based on our findings.

Verified
Journal Article
Open access
PDF file
AYAkiko Yamada
Akiko Yamada
AWAkira Watanabe
Akira Watanabe
ANAtsushi Nara
Atsushi Nara
NINaozumi Ishimaru
Naozumi Ishimaru
KMKosuke Maeda
Kosuke Maeda
TYTakenori Yamamoto
Takenori Yamamoto
Metabolic dysfunction-associated fatty liver disease (MAFLD) is one of the most common chronic liver diseases worldwide. Some patients with MAFLD develop metabolic dysfunction-associated steatohepatitis (MASH), which can lead to severe liver fibrosis. However, the molecular mechanisms underlying this progression remain unknown, and no effective treatment for MASH has been developed so far. In this study, we performed a longitudinal detailed analysis of mitochondria in the livers of choline-deficient, methionine-defined, high-fat-diet (CDAHFD)-fed mice, which exhibited a MASH-like pathology. We found that FoF1–ATPase activity began to decrease in the mitochondria of CDAHFD-fed mice prior to alterations in the activity of mitochondrial respiratory chain complex, almost at the time of onset of liver fibrosis. In addition, the decrease in FoF1–ATPase activity coincided with the accelerated opening of the mitochondrial permeability transition pore (PTP), for which FoF1–ATPase might be a major component or regulator. As fibrosis progressed, mitochondrial permeability transition (PT) induced in CDAHFD-fed mice became less sensitive to cyclosporine A, a specific PT inhibitor. These results suggest that episodes of fibrosis might be related to the disruption of mitochondrial function via PTP opening, which is triggered by functional changes in FoF1–ATPase. These novel findings could help elucidate the pathogenesis of MASH and lead to the development of new therapeutic strategies.

26 August 2025 in Cancers
Verified
Journal Article
Open access
PDF file
RFRei Fukui
Rei Fukui
SOShouhei Ogisawa
Shouhei Ogisawa
AYAkiko Yamada
Akiko Yamada
MAMasatake Asano
Masatake Asano
Background/Objectives: Interleukin-1 alpha (IL-1α) has been linked to tumor progression in various cancer types; however, its role in oral cancer pathogenesis remains largely unexplored. This study aimed to investigate the clinical significance of IL-1α expression in oral squamous cell carcinoma (OSCC), with a specific focus on its role in modulating cancer cell phenotype. Methods: Primary OSCC tissue specimens were collected from 104 patients and subjected to immunohistochemical analysis to assess IL-1α expression. OSCC cell lines were cultured for functional assays, and their protein and mRNA expressions were verified using western blotting and real-time polymerase chain reaction, respectively. The effects of IL-1α expression on OSCC cell proliferation, migration, and gene expression were subsequently examined. Results: IL-1α expression varied among OSCC tissues and cell lines both in vivo and in vitro. Notably, siRNA-mediated suppression of IL-1α in HSC3 cells impaired migration while leaving proliferation unaffected, highlighting its functional role in promoting cancer cell motility. Conclusions: Our in vivo and in vitro findings revealed varied IL-1α expression in OSCC and its association with a motile phenotype, suggesting that case-specific IL-1α assessment could hold prognostic value in oral cancer.

Verified
Journal Article
Open access
PDF file
AYAkiko Yamada
Akiko Yamada
AWAkira Watanabe
Akira Watanabe
ANAtsushi Nara
Atsushi Nara
TITsubasa Inokuma
Tsubasa Inokuma
MAMasatake Asano
Masatake Asano
TYTakenori Yamamoto
Takenori Yamamoto
Mitochondrial calcium (Ca2+) uptake plays a key role in mitochondrial physiology and disease development. This process is regulated by the mitochondrial calcium uniporter (MCU) complex. DS16570511 is a membrane-permeable drug that inhibits mitochondrial Ca2+ uptake, although its inhibitory mechanisms remain unclear. In this study, we evaluated the effects of DS16570511 on various mitochondrial functions through biochemical analyses. We found that DS16570511 affects multiple mitochondrial functions and exhibits variable potency in inhibiting individual processes. Specifically, DS16570511 not only inhibits MCU, its initially reported target, but also respiratory chain complexes and FoF1-adenosine triphosphatase/adenine nucleotide translocator, particularly respiratory chain complex II. Furthermore, the carboxyl group at the molecular terminus of DS16570511 plays a critical role in its inhibitory effects on mitochondrial Ca2+ uptake through respiratory chain complex II inhibition. These findings enhance our understanding of the mechanisms by which DS16570511 inhibits mitochondrial Ca2+ uptake and provide valuable insights for the clinical application of mitochondrial Ca2+ uptake inhibitors.

24 March 2023 in Research Square
Verified
Preprint
Open access
PDF file
AYAkiko Yamada
Akiko Yamada
KWKiyotaka Wake
Kiyotaka Wake
SISaya Imaoka
Saya Imaoka
MMMitsuru Motoyoshi
Mitsuru Motoyoshi
TYTakenori Yamamoto
Takenori Yamamoto
MAMasatake Asano
Masatake Asano
Interleukin-1α (IL-1α), a cytokine released by necrotic cells, causes sterile inflammation. On the other hand, IL-1α is present in the nucleus and also regulates the expression of many proteins. A protein substrate containing a nuclear localization signal (NLS) typically forms a substrate/importin α/β complex, which is subsequently transported to the nucleus. To the best of our knowledge, no study has directly investigated whether IL-1α—which includes NLS—is imported into the nucleus in an importin-dependent manner. In this study, we noted that all detected importin subtypes interacted with IL-1α. In HeLa cells, importin α1-mediated nuclear translocation of IL-1α occurred at steady state and was independent of importin β1. Importin α1 not only was engaged in IL-1α nuclear transport but also concurrently functioned as a molecule that regulated IL-1α protein level in the cell. Furthermore, we discussed the underlying mechanism of IL-1α nuclear translocation by importin α1 based on our findings.